MedTrace Logo

Comparison of BiCision® Versus UltraCision® During Laparoscopic Supracervical Hysterectomy (LASH)

NCT01752725 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2012-12-19

No results posted yet for this study

Summary

The aim of the study is the evaluation of the efficiency and safety of the new, CE-certified thermofu-sion and dissection instrument BiCision® in comparison with the long established Ultracision® Har-monic Scalpel(Ethicon)during a laparoscopic supracervical hysterectomy (LASH).

Conditions

  • Uterine Bleeding Disorders
  • Benign Uterine Conditions
  • Focus: Comparison of Two Instruments

Interventions

DEVICE

BiCision®

DEVICE

Ultracision® Har-monic Scalpel(Ethicon)

Sponsors & Collaborators

  • Erbe Elektromedizin GmbH

    collaborator INDUSTRY

  • University Hospital Tuebingen

    lead OTHER

Principal Investigators

  • Diethelm Wallwiener, Professor · University Hospital Tuebingen

  • Bernhard Krämer, MD · University Hospital Tuebingen

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2012-04-30
Completion
2012-04-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01752725 on ClinicalTrials.gov